Nancy Mace actually said...

"If you have three companies making up the vast majority, that is not really competitive at all of an industry."

"Do PBMs often exclude lower-cost generics in favor of high-cost branded drugs, effectively eliminating the benefit of the short patent on drugs?"

"We want consumers to have choices, competition, and lower prescription drug prices."

"You also expressed concerns that PBMs, which are often vertically integrated with their own pharmacies, are using their pricing power to harm independent pharmacies."